BeckRW, RiddlesworthTD, RuedyK, et al: Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily injections: a randomized trial. Ann Intern Med, 2017; 167:365–374.
3.
HaakT, HanaireH, AijanR, et al.: Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multi-center, open-label, randomized controlled trial. Diabetes Ther, 2017; 8:55–73.
4.
DrazninB, NathanDM, KorytkowskiMT, et al.: Guidelines versus guidelines. Ann Intern Med, 2018; 169:896–897.
5.
BergenstalRM, BeckRW, CloseKL, et al.: Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care, 2018; 41:2275–2280.
6.
AdamsAL, PaxtonEW, WangJQ, et al.: Surgical outcome of total knee replacement according to diabetes status and glycemic control, 2001–2009. J Bone Joint Surg Am, 2013; 95:481–487.
7.
UnderwoodP, AskariR, HurwitzS, et al.: Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care, 2014; 37:611–616.
8.
RubinowKB, HirschIB: Reexamining the metrics for glucose control. JAMA, 2011; 305:1132–1133.
9.
HopkinsJS: Drug makers raise prices on hundreds of medicines. Wall St J January, 1, 2019.
10.
HerkertD, VijayakumarBA, LuoJ, et al.: Cost-related insulin underuse among patients with diabetes. JAMA Intern Med, 2019; 179(1):112–114 DOI: 10.1001/jamainternmed.2018.5008.
